Calico Life Sciences is a biotechnology research company focused on understanding the biology of aging and developing interventions to enable people to live longer, healthier lives. The organization emphasizes translational science and uses advanced technology and computing to explore aging mechanisms, with collaborations across academia and other biopharmaceutical companies. It operates as a research-driven entity in the United States, combining elements of academic inquiry and industry development to build a pipeline of early- and clinical-stage compounds targeting aging-related diseases.
No recent news for this company.
No recent deals for this company.